Europe

Edwards Lifesciences wins CE Mark for Sapien 3 Ultra TAVR
Edwards Lifesciences wins CE Mark for Sapien 3 Ultra TAVR
Mass Device
Edwards Lifesciences
CE Mark
Europe
Sapien 3
TAVR
devices
Flag link:
Biopharma may have to wait for Brexit details
Biopharma may have to wait for Brexit details
BioCentury
Brexit
Europe
UK
Flag link:
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Takeda
Shire
M&A
Europe
Flag link:
#WeWontRest: The benefits of giving pharma a face
#WeWontRest: The benefits of giving pharma a face
Pharmaforum
Europe
pharma industry
social media
Flag link:
Half of Clinical Trials Fail to Publish Results, UK Report Finds
Half of Clinical Trials Fail to Publish Results, UK Report Finds
RAPS.org
clinical trials
UK
Europe
transparency
Flag link:
Reimbursement lags cancer drug approvals, but some European countries wait longer
Reimbursement lags cancer drug approvals, but some European countries wait longer
Biopharma Dive
Europe
drug approvals
reimbursement
Flag link:
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Flag link:
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
Fierce Biotech
Europe
Novartis
ESMO
AstraZeneca
breast cancer
BYL719
Flag link:
Shire's drug for rare swelling disorder wins European panel green light
Shire's drug for rare swelling disorder wins European panel green light
Reuters
EMA
Europe
Shire
Takhzyro
HAE
Flag link:
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
Fierce Pharma
Humira
AbbVie
Fresenius Kabi
Europe
Flag link:
What “no-deal” Brexit means for medical devices
What “no-deal” Brexit means for medical devices
Emergo
UK
Europe
Brexit
devices
Flag link:
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Flag link:
Novartis bets PRV on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Novartis bets PRV on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Endpoints
Novartis
siponimod
MS
multiple sclerosis
Europe
Flag link:
European biotech funding on track for record year
European biotech funding on track for record year
Fierce Biotech
Europe
biotech
Flag link:
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
CP Wire
Bluebird Bio
transfusion-dependent anemia
LentiGlobin
EMA
Europe
Flag link:
Spark/Novartis eye gene therapy nears EU market – but at what price?
Spark/Novartis eye gene therapy nears EU market – but at what price?
Pharmaforum
Spark Therapeutics
Novartis
Luxturna
gene therapy
Europe
Flag link:
Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again
Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again
Xconomy
Europe
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
eteplirsen
Flag link:
5th Humira biosimilar approved in EU as market entry nears
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Europe
biosimilars
AbbVie
Humira
Mylan
Hulio
Flag link:
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
JNJ
Janssen
Darzalex
daratumumab
Europe
Multiple Myeloma
Flag link:
Half of Europe's clinical trials fail to report results despite EU rule
Half of Europe's clinical trials fail to report results despite EU rule
Reuters
Europe
clinical trials
Flag link:

Pages